|
| It's prior year ROE (using book equity of $53.56/share) is 69.17%. That is juicy even at 5 times book.
It's price could sure get cut in half if growth slows, but if it goes much more than that, I'd buy. This thing generates ebitda with real growth, unlike a tulip.
My guts says it feels ripe for a pullback still. I could probably cut some loser stocks out to negate cap gains on a trim. The whole market seems extended to me - but stocks climb a wall of worry. | |
|
NVDA larger than AMZN
